HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,454,065 | +13.1% | 38,500 | +0.5% | 0.06% | +16.4% |
| Q2 2023 | $3,939,155 | -8.4% | 38,300 | -2.8% | 0.06% | -11.3% |
| Q1 2023 | $4,300,116 | -3.9% | 39,400 | +0.3% | 0.06% | -12.7% |
| Q4 2022 | $4,472,340 | +79.8% | 39,300 | -2.2% | 0.07% | +73.2% |
| Q3 2022 | $2,487,000 | -22.0% | 40,200 | +0.5% | 0.04% | -19.6% |
| Q2 2022 | $3,190,000 | -22.1% | 40,000 | +2.8% | 0.05% | -5.6% |
| Q1 2022 | $4,093,000 | -4.1% | 38,900 | -1.8% | 0.05% | +1.9% |
| Q4 2021 | $4,267,000 | -1.4% | 39,600 | +0.3% | 0.05% | -10.2% |
| Q3 2021 | $4,327,000 | +11.1% | 39,500 | -5.0% | 0.06% | +18.0% |
| Q2 2021 | $3,895,000 | +12.8% | 41,600 | +10.9% | 0.05% | +4.2% |
| Q1 2021 | $3,452,000 | +20.4% | 37,500 | -4.3% | 0.05% | +17.1% |
| Q4 2020 | $2,868,000 | -1.5% | 39,200 | +4.5% | 0.04% | -14.6% |
| Q3 2020 | $2,913,000 | +580.6% | 37,500 | +387.0% | 0.05% | +500.0% |
| Q2 2020 | $428,000 | +85.3% | 7,700 | -1.3% | 0.01% | +60.0% |
| Q1 2020 | $231,000 | -18.1% | 7,800 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $282,000 | +34.3% | 7,800 | +1.3% | 0.01% | +25.0% |
| Q3 2019 | $210,000 | – | 7,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |